R H Mindham, R Gaind, B H Anstee, L Rimmer. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Affect/drug effectsAmantadine/administration & dosageAmantadine/adverse effectsAmantadine/therapeutic useBasal Ganglia Diseases/chemically inducedBasal Ganglia Diseases/drug therapyClinical Trials as TopicEvaluation Studies as TopicFemaleFluphenazine/adverse effectsHumansMaleOrphenadrine/administration & dosageOrphenadrine/adverse effectsOrphenadrine/therapeutic useParkinson Disease/drug therapyParkinson Disease, Secondary/chemically inducedPlacebosSchizophrenia/drug therapy
Substances: See more » PlacebosOrphenadrineAmantadineFluphenazine
Year: 1972 PMID: 4571143 DOI: 10.1017/s0033291700045220
Source DB: PubMed Journal: Psychol Med ISSN: 0033-2917 Impact factor: 7.723